These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 32857878)

  • 1. Thrombosis in COVID-19.
    Hanff TC; Mohareb AM; Giri J; Cohen JB; Chirinos JA
    Am J Hematol; 2020 Dec; 95(12):1578-1589. PubMed ID: 32857878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.
    Miesbach W; Makris M
    Clin Appl Thromb Hemost; 2020; 26():1076029620938149. PubMed ID: 32677459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Longitudinal Immune Response to Coronavirus Disease 2019: Chasing the Cytokine Storm.
    Chau AS; Weber AG; Maria NI; Narain S; Liu A; Hajizadeh N; Malhotra P; Bloom O; Marder G; Kaplan B
    Arthritis Rheumatol; 2021 Jan; 73(1):23-35. PubMed ID: 32929876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activation and coagulopathy - an ominous duo in COVID19.
    Tomo S; Kumar KP; Roy D; Sankanagoudar S; Purohit P; Yadav D; Banerjee M; Sharma P; Misra S
    Expert Rev Hematol; 2021 Feb; 14(2):155-173. PubMed ID: 33480807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the COVID-19 thrombotic catastrophe complement-connected?
    Conway EM; Pryzdial ELG
    J Thromb Haemost; 2020 Nov; 18(11):2812-2822. PubMed ID: 32762081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombotic Complications of COVID-19 Infection: A Review.
    Castro RA; Frishman WH
    Cardiol Rev; 2021; 29(1):43-47. PubMed ID: 32947478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reality Check on Antiphospholipid Antibodies in COVID-19-Associated Coagulopathy.
    Gkrouzman E; Barbhaiya M; Erkan D; Lockshin MD
    Arthritis Rheumatol; 2021 Jan; 73(1):173-174. PubMed ID: 32901454
    [No Abstract]   [Full Text] [Related]  

  • 8. COVID-19-associated coagulopathy and disseminated intravascular coagulation.
    Asakura H; Ogawa H
    Int J Hematol; 2021 Jan; 113(1):45-57. PubMed ID: 33161508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulopathy in COVID-19: Focus on vascular thrombotic events.
    Shi W; Lv J; Lin L
    J Mol Cell Cardiol; 2020 Sep; 146():32-40. PubMed ID: 32681845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad.
    Ahmed S; Zimba O; Gasparyan AY
    Clin Rheumatol; 2020 Sep; 39(9):2529-2543. PubMed ID: 32654082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covid-19, induced activation of hemostasis, and immune reactions: Can an auto-immune reaction contribute to the delayed severe complications observed in some patients?
    Amiral J; Vissac AM; Seghatchian J
    Transfus Apher Sci; 2020 Jun; 59(3):102804. PubMed ID: 32387238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential mechanisms of cerebrovascular diseases in COVID-19 patients.
    Lou M; Yuan D; Liao S; Tong L; Li J
    J Neurovirol; 2021 Feb; 27(1):35-51. PubMed ID: 33534131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral Coagulopathy in Patients With COVID-19: Treatment and Care.
    Kipshidze N; Dangas G; White CJ; Kipshidze N; Siddiqui F; Lattimer CR; Carter CA; Fareed J
    Clin Appl Thromb Hemost; 2020; 26():1076029620936776. PubMed ID: 32687449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis and Treatment Strategies of COVID-19-Related Hypercoagulant and Thrombotic Complications.
    Haimei MA
    Clin Appl Thromb Hemost; 2020; 26():1076029620944497. PubMed ID: 32722927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication.
    Ning Q; Wu D; Wang X; Xi D; Chen T; Chen G; Wang H; Lu H; Wang M; Zhu L; Hu J; Liu T; Ma K; Han M; Luo X
    Signal Transduct Target Ther; 2022 Feb; 7(1):57. PubMed ID: 35197452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous Thrombosis and SARS-CoV-2.
    Zdanyte M; Rath D; Gawaz M; Geisler T
    Hamostaseologie; 2022 Aug; 42(4):240-247. PubMed ID: 34879422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 and Its Implications for Thrombosis and Anticoagulation.
    Berkman SA; Tapson VF
    Semin Respir Crit Care Med; 2021 Apr; 42(2):316-326. PubMed ID: 33548929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prothrombotic Milieu, Thrombotic Events and Prophylactic Anticoagulation in Hospitalized COVID-19 Positive Patients: A Review.
    Cryer MJ; Farhan S; Kaufmann CC; Jäger B; Garg A; Krishnan P; Mehran R; Huber K
    Clin Appl Thromb Hemost; 2022; 28():10760296221074353. PubMed ID: 35068227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection.
    Obi AT; Barnes GD; Napolitano LM; Henke PK; Wakefield TW
    J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):23-35. PubMed ID: 32916371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation for COVID-19 Patients: A Bird's-Eye View.
    Kreidieh F; Temraz S
    Clin Appl Thromb Hemost; 2021; 27():10760296211039288. PubMed ID: 34595937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.